BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17276403)

  • 1. 3-Methylcholanthrene elicits DNA adduct formation in the CYP1A1 promoter region and attenuates reporter gene expression in rat H4IIE cells.
    Moorthy B; Muthiah K; Fazili IS; Kondraganti SR; Wang L; Couroucli XI; Jiang W
    Biochem Biophys Res Commun; 2007 Mar; 354(4):1071-7. PubMed ID: 17276403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycyclic aromatic hydrocarbon-inducible DNA adducts: evidence by 32P-postlabeling and use of knockout mice for Ah receptor-independent mechanisms of metabolic activation in vivo.
    Kondraganti SR; Fernandez-Salguero P; Gonzalez FJ; Ramos KS; Jiang W; Moorthy B
    Int J Cancer; 2003 Jan; 103(1):5-11. PubMed ID: 12455047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of expression of hepatic and pulmonary cytochrome P4501A enzymes by 3-methylcholanthrene in mice lacking the CYP1A2 gene.
    Kondraganti SR; Jiang W; Moorthy B
    J Pharmacol Exp Ther; 2002 Dec; 303(3):945-51. PubMed ID: 12438513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Cyp1a1 and Cyp1b1 and formation of DNA adducts in C57BL/6, Balb/c, and F1 mice following in utero exposure to 3-methylcholanthrene.
    Xu M; Nelson GB; Moore JE; McCoy TP; Dai J; Manderville RA; Ross JA; Miller MS
    Toxicol Appl Pharmacol; 2005 Nov; 209(1):28-38. PubMed ID: 15885734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anticancer drug ellipticine is a potent inducer of rat cytochromes P450 1A1 and 1A2, thereby modulating its own metabolism.
    Aimová D; Svobodová L; Kotrbová V; Mrázová B; Hodek P; Hudecek J; Václavíková R; Frei E; Stiborová M
    Drug Metab Dispos; 2007 Oct; 35(10):1926-34. PubMed ID: 17656468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent induction of cytochrome P450 (CYP)1A enzymes by 3-methylcholanthrene in vivo in mice is mediated by sustained transcriptional activation of the corresponding promoters.
    Jiang W; Wang L; Zhang W; Coffee R; Fazili IS; Moorthy B
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1419-24. PubMed ID: 19900403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of the gene for CYP1A2, which is expressed primarily in liver, leads to differential regulation of hepatic and pulmonary mouse CYP1A1 expression and augmented human CYP1A1 transcriptional activation in response to 3-methylcholanthrene in vivo.
    Jiang W; Wang L; Kondraganti SR; Fazili IS; Couroucli XI; Felix EA; Moorthy B
    J Pharmacol Exp Ther; 2010 Nov; 335(2):369-79. PubMed ID: 20732958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of P450 1A1 and P450 1A2 in bioactivation versus detoxication of the renal carcinogen aristolochic acid I: studies in Cyp1a1-/-, Cyp1a2-/-, and Cyp1a1/1a2-/- mice.
    Arlt VM; Levová K; Bárta F; Shi Z; Evans JD; Frei E; Schmeiser HH; Nebert DW; Phillips DH; Stiborová M
    Chem Res Toxicol; 2011 Oct; 24(10):1710-9. PubMed ID: 21932800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of 3-methylcholanthrene-induced bioactivation in the human hepatoma cell line HepG2 by the calcium channel blocker nicardipine.
    Hosaka T; Sekimoto M; Nemoto K; Degawa M
    Cancer Sci; 2010 Mar; 101(3):652-7. PubMed ID: 20067464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high-throughput cell-based reporter gene system for measurement of CYP1A1 induction.
    Cui X; Palamanda J; Norton L; Thomas A; Lau YY; White RE; Cheng KC
    J Pharmacol Toxicol Methods; 2002; 47(3):143-51. PubMed ID: 12628305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oltipraz inhibits 3-methylcholanthrene induction of CYP1A1 by CCAAT/enhancer-binding protein activation.
    Cho IJ; Kim SG
    J Biol Chem; 2003 Nov; 278(45):44103-12. PubMed ID: 12941938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactivation versus detoxication of the urothelial carcinogen aristolochic acid I by human cytochrome P450 1A1 and 1A2.
    Stiborová M; Levová K; Bárta F; Shi Z; Frei E; Schmeiser HH; Nebert DW; Phillips DH; Arlt VM
    Toxicol Sci; 2012 Feb; 125(2):345-58. PubMed ID: 22086975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of DNA adduct formation of PhIP in female F344 rats by dietary conjugated linoleic acid.
    Josyula S; He YH; Ruch RJ; Schut HA
    Nutr Cancer; 1998; 32(3):132-8. PubMed ID: 10050262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential activities of CYP1A isozymes in hepatic and intestinal microsomes of control and 3-methylcholanthrene-induced rats.
    Spatzenegger M; Horsmans Y; Verbeeck RK
    Pharmacol Toxicol; 2000 Feb; 86(2):71-7. PubMed ID: 10728918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Methylcholanthrene-inducible hepatic DNA adducts: a mechanistic hypothesis linking sequence-specific DNA adducts to sustained cytochrome P4501A1 induction by 3-methylcholanthrene.
    Moorthy B
    Redox Rep; 2002; 7(1):9-13. PubMed ID: 11981449
    [No Abstract]   [Full Text] [Related]  

  • 16. Persistent expression of 3-methylcholanthrene-inducible cytochromes P4501A in rat hepatic and extrahepatic tissues.
    Moorthy B
    J Pharmacol Exp Ther; 2000 Jul; 294(1):313-22. PubMed ID: 10871328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omeprazole transactivates human CYP1A1 and CYP1A2 expression through the common regulatory region containing multiple xenobiotic-responsive elements.
    Yoshinari K; Ueda R; Kusano K; Yoshimura T; Nagata K; Yamazoe Y
    Biochem Pharmacol; 2008 Jul; 76(1):139-45. PubMed ID: 18502397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upstream stimulatory factor 1 (USF1) suppresses induction of CYP1A1 mRNA by 3-methylcholanthrene (MC) in HepG2 cells.
    Takahashi Y; Nakayama K; Itoh S; Kamataki T
    Biochem Biophys Res Commun; 1997 Nov; 240(2):293-7. PubMed ID: 9388470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of Ah receptor to mediate induction of cytochromes P450 in the CYP1 family in the human hepatoma line SK-Hep-1.
    Roberts EA; Harper PA; Wong JM; Wang Y; Yang S
    Arch Biochem Biophys; 2000 Dec; 384(1):190-8. PubMed ID: 11147830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.
    Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M
    Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.